Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiac296 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von M Cristina Cassetti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Mar…. Hauptthemen laut MEDLINE: Pandemics, Vaccines. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases, National Institutes of Health.
Abstract (Originalsprache)
Severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) emerged 20 years ago, presaging a series of subsequent infectious disease epidemics of international concern. The recent emergence of SARS-CoV-2 has underscored the importance of targeted preparedness research to enable rapid countermeasure development during a crisis. In December 2021 the National Institute of Allergy and Infectious Diseases (NIAID), building upon the successful strategies developed during the SARS-CoV-2 response and to prepare for future pandemics, published a pandemic preparedness plan that outlined a research strategy focused on priority pathogens, technology platforms, and prototype pathogens. To accelerate the discovery, development, and evaluation of medical countermeasures against new or previously unknown pathogens of pandemic potential, we present here a strategy of research directed at select prototype pathogens. In this manner, leveraging a prototype pathogen approach may serve as a powerful cornerstone in biomedical research preparedness to protect public health from newly emerging and reemerging infectious diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Förderung
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
Zitieren
APA
Cassetti, M. C., Pierson, T. C., Patterson, L. J., Bok, K., DeRocco, A. J., Deschamps, A. M., Graham, B. S., Erbelding, E. J., & Fauci, A. S. (2023). Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiac296
Vancouver
Cassetti MC, Pierson TC, Patterson LJ, Bok K, DeRocco AJ, Deschamps AM, et al. Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiac296
BibTeX
@article{Cassetti2023,
author = {Cassetti, M Cristina and Pierson, Theodore C and Patterson, L Jean and Bok, Karin and DeRocco, Amanda J and Deschamps, Anne M and Graham, Barney S and Erbelding, Emily J and Fauci, Anthony S},
title = {Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiac296}
}
EUVIMED